Pasithea Therapeutics Corp.
KTTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $4 | $1 | $3 |
| - Cash | $4,123 | $7 | $5 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$4,118 | -$3 | -$4 | -$3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$4 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$4 | -$4 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.66 | -3.25 | -2.9 |
| % Growth | 37.9% | 79.7% | -12.1% | – |
| Operating Cash Flow | -$3 | -$4 | -$3 | -$2 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$4 | -$3 | -$2 |